Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
Public ClinicalTrials.gov record NCT04291105. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Patients With Select Solid Tumors
Study identification
- NCT ID
- NCT04291105
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Vyriad, Inc.
- Industry
- Enrollment
- 87 participants
Conditions and interventions
Interventions
- Cemiplimab Biological
- VV1 Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 23, 2020
- Primary completion
- May 31, 2025
- Completion
- Nov 30, 2025
- Last update posted
- Mar 25, 2025
2020 – 2025
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinical | Phoenix | Arizona | 85054 | Withdrawn |
| City of Hope Medical Center | Durate | California | 91010 | Withdrawn |
| USC Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | Withdrawn |
| HOAG Memorial Hospital Presbyterian | Newport Beach | California | 92663 | Withdrawn |
| Saint John's Health Center - John Wayne Cancer Institute (JWCI) | Santa Monica | California | 90404 | Terminated |
| Stanford Health Care | Stanford | California | 94305 | Withdrawn |
| Yale University | New Haven | Connecticut | 06520-8032 | Recruiting |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | Withdrawn |
| Mayo Clinical | Jacksonville | Florida | 32224 | Withdrawn |
| University of Miami | Miami | Florida | 33136 | Completed |
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | Recruiting |
| Massachusetts General Hospital Cancer Center | Boston | Massachusetts | 02114 | Withdrawn |
| Masonic Cancer Center, University of Minnesota | Minneapolis | Minnesota | 55455 | Withdrawn |
| Mayo Clinic | Rochester | Minnesota | 55905 | Recruiting |
| Billings Clinic Montana Cancer Consortium | Billings | Montana | 59101 | Terminated |
| Atlantic Health | Morristown | New Jersey | 07960 | Withdrawn |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08901 | Withdrawn |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | Recruiting |
| University of Cincinnati Medical Center | Cincinnati | Ohio | 45219 | Recruiting |
| Ohio State University | Columbus | Ohio | 43210 | Withdrawn |
| UPMC | Pittsburgh | Pennsylvania | 15213 | Withdrawn |
| Sanford Cancer Center | Sioux Falls | South Dakota | 57104 | Recruiting |
| UT Health San Antonio MD Anderson Cancer Center | San Antonio | Texas | 78229 | Withdrawn |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04291105, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 25, 2025 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04291105 live on ClinicalTrials.gov.